FIELD: biochemistry.
SUBSTANCE: invention relates to a method for increasing the immunogenicity of a protein/peptide antigen. There are disclosed a conjugate for use in said method, an immunogenic composition containing said conjugate. Also disclosed is the use of said conjugate to increase immunogenicity.
EFFECT: invention enables to increase immunogenicity effectively.
58 cl, 4 dwg, 8 tbl, 6 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| STABILIZED F RSV PROTEINS AND THEIR USE | 2019 | 
 | RU2795459C2 | 
| MODIFIED J-STRAIN | 2015 | 
 | RU2761118C2 | 
| VACCINE AGAINST FELINE LEUKEMIA VIRUS | 2018 | 
 | RU2784533C2 | 
| SUBUNIT VACCINE FOR TREATING OR PREVENTING RESPIRATORY TRACT INFECTION | 2020 | 
 | RU2811991C2 | 
| VACCINE AGAINST FELINE CALICIVIRUS | 2018 | 
 | RU2792898C2 | 
| FIMH ESCHERICHIA COLI MUTANTS AND USE THEREOF | 2021 | 
 | RU2831010C1 | 
| ANTIBODY TO TIGIT AND ITS USE | 2019 | 
 | RU2786434C2 | 
| SELF-ASSEMBLED NANOSTRUCTURED VACCINES | 2019 | 
 | RU2811439C2 | 
| FUSION PROTEIN BASED ON ANTI-ETA AND TGF-β TRAP ANTIBODIES, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 2020 | 
 | RU2832190C2 | 
| RSV F MUTANT PROTEIN AND ITS APPLICATION | 2020 | 
 | RU2807742C1 | 
Authors
Dates
2024-11-25—Published
2021-04-29—Filed